- Report
- July 2023
- 114 Pages
Global
From €5289EUR$5,500USD£4,541GBP
- Report
- December 2023
- 288 Pages
Global
From €5385EUR$5,600USD£4,623GBP
- Report
- May 2023
- 250 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- January 2023
- 112 Pages
Global
From €2403EUR$2,499USD£2,063GBP
- Report
- January 2023
- 170 Pages
Global
From €2404EUR$2,500USD£2,064GBP
- Report
- November 2023
- 70 Pages
United States
From €3366EUR$3,500USD£2,889GBP
- Report
- September 2023
- 110 Pages
Global
From €5722EUR$5,950USD£4,912GBP
- Report
- June 2023
- 275 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- April 2023
- 200 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- January 2023
- 197 Pages
Global
From €3046EUR$3,168USD£2,615GBP
€3462EUR$3,600USD£2,972GBP
- Report
- June 2023
- 277 Pages
Global
From €5597EUR$5,820USD£4,805GBP
- Report
- August 2023
- 145 Pages
Global
From €3029EUR$3,150USD£2,600GBP
- Report
- August 2023
- 85 Pages
Europe
From €3883EUR$4,038USD£3,333GBP
€4568EUR$4,750USD£3,921GBP
- Report
- April 2023
- 90 Pages
Asia Pacific
From €3883EUR$4,038USD£3,333GBP
€4568EUR$4,750USD£3,921GBP
- Report
- October 2023
- 243 Pages
Global
From €4762EUR$5,125USD£3,950GBP
- Report
- June 2023
- 58 Pages
Global
From €1923EUR$2,000USD£1,651GBP
- Report
- October 2023
- 142 Pages
Global
From €2403EUR$2,499USD£2,063GBP
- Report
- June 2023
- 78 Pages
Global
From €4760EUR$4,950USD£4,086GBP
- Report
- January 2023
- 197 Pages
Global
From €3046EUR$3,168USD£2,615GBP
€3462EUR$3,600USD£2,972GBP
- Report
- June 2023
- 117 Pages
Global
From €3798EUR$3,950USD£3,261GBP

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more